A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants

American Journal of Surgery

Volumn 177, Issue 4, 1999, Pages 299-302

  Raofi, Vandad ^a   Holman, Dawn M ^a   Coady, Noreen ^a   Vazquez, Eva ^a   Dunn, Ty B ^a   Bartholomew, Amelia M ^a   Pollak, Raymond ^a   Benedetti, Enrico ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOSPORIN A; METHYLPREDNISOLONE; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT REJECTION; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AZATHIOPRINE; CADAVER; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 0032920587     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)00042-2     Document Type: Article

References (29)

1. 1997 OPTN Annual Report. UNOS Scientific Registry.
2. Opelz G., Wujciak T., Schwartz V., et al. Collaborative transplant study analysis of graft survival in blacks. Trans Proc. 25:1993;2443-2445.
3. Abrams J., Smolinski S., Nathan H., Moritz M. Cadaveric renal transplant in the highly sensitized African-American patient. Trans Proc. 25:1993;2479-2480.
4. Cecka J.M. Outcome statistics for renal transplants with an emphasis on long-term survival. Clin Transplant. 8:1994;324-327.
5. Kerman R.H., Kimball P.M., Van Buren C.T., et al. Possible contribution of pretransplant immune responder status to renal allograft survival. Differences of black versus white recipients. Transplantation. 51:1991;338-342.
6. Benedetti E., Freels S., Coady N., et al. The impact of quadruple immunosuppression with OKT3 in kidney transplantation in black recipients. Am J Surg. 173:1996;56-60.
7. Gaston R., Hudson S., Deierhoi M., et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation. 53:1992;103-109.
8. Cecka J., Gjertson D., Cho Y., Terasaki P. HLA polymorphisms, ethnicity, and graft survival United Network for Organ Sharing . Trans Proc. 25:1993;2446-2447.
9. Cecka J., Cho Y., Terasaki P. Analyses of the UNOS scientific renal transplant registry at three years - early events affecting transplant success. Transplantation. 53:1992;59-64.
10. Hooks M.H. FK506, a new immunosuppressant - a review of the literature. Ann Pharmacother. 28:1994;501-510.
11. Vasquez E.M., Sanchez J., Pollak R., et al. High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. Transplantation. 55:1993;448-450.
12. Koyama H., Cecka J.M., Terasaki P.I. Kidney transplant in black recipients - HLA matching and other factors affecting long-term graft survival. Transplantation. 57:1994;1064-1068.
13. Opelz G., Pfarr E., Engelmann A., Keppel E. Kidney graft survival rates in black CSA-treated recipients. Trans Proc. 21:1989;3918-3920.
14. Yuge J., Cecka J.M. The race effect. Clin Transplants 1989. 1989;407-421 UCLA Tissue Typing Laboratory, Los Angeles.
15. Matas A.J., Tellis V.A., Perez L., et al. Does race affect renal transplant results? A single institution study. Clin Transplant. 1:1987;261-264.
16. Dawidson I.J.A., Cooepender L., Fisher D., et al. Impact of race on renal transplant outcome. Transplantation. 49:1990;63-67.
17. McCauley J., Shapiro R., Woods C., et al. Renal transplantation under FK506 in African-Americans early experience . Trans Proc. 25:1993;2468-2469.
18. Dunn J., Vathsala A., Golde D., et al. Impact of race on the outcome of renal transplantation under CSA-prednisone. Trans Proc. 21:1989;3946-3947.
19. Rovelli M., Palmeri D., Vossler E., et al. Noncompliance in renal transplant recipients evaluation by socioeconomic groups . Trans Proc. 21:1989;3979-3980.
20. Terasaki P.I., Chia D., Mickey M.R. The second histocompatability locus in humans. Trans Proc. 20:(suppl 1):1988;21-25.
21. Gjertson D.W. Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry a 1994 update . Terasaki P.I., Cecka J.M. Clinical Transplants 1994. 1995;519 UCLA Tissue Typing Laboratory, Los Angeles.
22. Ross W., Solomon H., Reese J., et al. Beneficial effects of HLA-DR3 gene expression on renal allograft survival in black recipients. Trans Proc. 25:1993;2408-2410.
23. Tesi R.J., Dagaglou P., Zarifian A., Ethredge E. New immunosuppression strategies are needed to improve kidney allograft survival in blacks. Trans Proc. 28:1996;2125-2127.
24. Laskow D., Vincenti F., Neylan J., et al. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation. Transplantation. 62:1996;900-905.
25. Mayer A., Dmitrewski J., Squifflet J.P., et al. Multicenter randomized trial comparing FK506 and CSA in the prevention of renal allograft rejection. Transplantation. 64:1997;436-443.
26. Neylan J.F. Racial differences in renal transplantation after immunosuppression with FK506 versus CSA. Transplantation. 65:1998;515-523.
27. Almond P.S., Matos A., Gillingham K.J., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation. 55:1993;752-757.
28. Lindholm A., Ohlman S., Albrechtsem D., et al. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation. 56:1993;307-315.
29. Flechner S.M., Madlin C.S., Serrano D.P., et al. Determinants of chronic renal allograft rejection in cyclosporine treated patients. Transplantation. 62:1996;1235-1241.